tiprankstipranks
Phasebio Pharmaceuticals (PHASQ)
OTHER OTC:PHASQ
US Market
Holding PHASQ?
Track your performance easily

Phasebio Pharmaceuticals (PHASQ) Financial Statements

692 Followers

Phasebio Pharmaceuticals Financial Overview

Phasebio Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Phasebio Pharmaceuticals is scheduled to report earnings on August 15, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement-
Total Revenue$ 208.00K$ 117.00K$ 158.00K$ 335.00K$ 10.34M
Gross Profit$ 208.00K$ 117.00K---
EBIT$ -16.55M$ -10.99M$ -42.92M$ -31.70M$ -26.82M
EBITDA$ -15.95M$ -10.39M$ -42.32M$ -31.57M$ -26.24M
Net Income Common Stockholders$ -16.66M$ -11.14M$ -43.11M$ -31.92M$ -28.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.80M$ 18.70M$ 41.80M$ 56.36M$ 64.46M
Total Assets$ 22.17M$ 38.66M$ 60.54M$ 77.72M$ 100.64M
Total Debt$ 4.94M$ 6.39M$ 8.32M$ 9.78M$ 11.24M
Net Debt$ -2.86M$ -12.31M$ -33.48M$ -46.57M$ -53.22M
Total Liabilities$ 139.56M$ 141.06M$ 153.57M$ 128.05M$ 119.81M
Stockholders Equity$ -117.40M$ -102.39M$ -93.03M$ -50.33M$ -19.18M
Cash Flow-
Free Cash Flow$ -10.47M$ -22.93M$ -21.65M$ -6.77M$ -11.34M
Operating Cash Flow$ -10.41M$ -22.88M$ -19.99M$ -6.13M$ -11.09M
Investing Cash Flow$ -58.00K$ -49.00K$ -1.66M$ -638.00K$ -252.00K
Financing Cash Flow$ -415.00K$ -179.00K$ 7.09M$ -1.33M$ -1.17M
Currency in USD

Phasebio Pharmaceuticals Earnings and Revenue History

Phasebio Pharmaceuticals Debt to Assets

Phasebio Pharmaceuticals Cash Flow

Phasebio Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis